KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Guardant Health (GH) over the last 8 years, with Q3 2025 value amounting to $94.4 million.

  • Guardant Health's Other Non-Current Liabilities rose 549.27% to $94.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.4 million, marking a year-over-year increase of 549.27%. This contributed to the annual value of $92.8 million for FY2024, which is 330.4% down from last year.
  • As of Q3 2025, Guardant Health's Other Non-Current Liabilities stood at $94.4 million, which was up 549.27% from $91.2 million recorded in Q2 2025.
  • Guardant Health's Other Non-Current Liabilities' 5-year high stood at $96.8 million during Q1 2024, with a 5-year trough of $1.7 million in Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $9.4 million (2023), whereas its average is $43.2 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 95939.14% in 2024, then plummeted by 496.59% in 2025.
  • Guardant Health's Other Non-Current Liabilities (Quarter) stood at $3.9 million in 2021, then skyrocketed by 133.38% to $9.2 million in 2022, then soared by 945.93% to $96.0 million in 2023, then fell by 3.3% to $92.8 million in 2024, then increased by 1.64% to $94.4 million in 2025.
  • Its last three reported values are $94.4 million in Q3 2025, $91.2 million for Q2 2025, and $92.5 million during Q1 2025.